The company Movie Games, which published the drug dealer simulator dilogy Drug Dealer Simulator, suspects the creators of the indie hit Schedule I of infringing on its copyrights. The company has decided to investigate the game for plagiarism.
Drug Dealer Simulator 2 — on the left, Schedule I — on the right
Movie Games launched a special investigation on March 25th, the day Schedule I was released in early access on Steam. According to the company, it has since identified numerous potentially contentious points.
In particular, Movie Games suspects that the creators of Schedule I may have borrowed story elements, interface components, and some gameplay mechanics from Drug Dealer Simulator.
Currently, Movie Games continues to evaluate the game. It has reached out to unnamed international law firms, which will assist its lawyers in clarifying the situation. The company will file a lawsuit against the TVGS studio if its suspicions are confirmed.
Notably, Schedule I has already significantly surpassed both the first and second parts of Drug Dealer Simulator in popularity. Its peak online presence on Steam reached 414,166 people, whereas neither iteration of Drug Dealer Simulator even approached the 10,000 mark.
The sales figures for Schedule I have not been officially disclosed, but Movie Games estimates them to be close to 3 million copies. For comparison, the first Drug Dealer Simulator sold a million copies over the five years since its release, and the sales of its sequel as of mid-March 2025 stood at 250,000 copies.
In Russia, the production, distribution, acquisition, storage, transportation, processing, and promotion of narcotics are prohibited. Their use is harmful to health.